These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7376128)

  • 21. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 22. ["Low-dose heparin" and other methods to prevent thrombo-embolism in gynaecological surgery (author's transl)].
    Lehmann R; Severin W
    Zentralbl Gynakol; 1980; 102(21):1247-53. PubMed ID: 6163267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Low-dose heparin and acetyl-salicylic acid after elective operations on the hip joint (author's transl)].
    Schöndorf TH; Weber U; Lasch HG
    Dtsch Med Wochenschr; 1977 Sep; 102(37):1314-8. PubMed ID: 902597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prophylaxis of thrombosis in surgical gynecology and obstetrics (author's transl)].
    Voigt T; Voigt H
    Zentralbl Gynakol; 1980; 102(24):1401-9. PubMed ID: 6164182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of post-traumatic or postoperative thromboembolitic complications with calcium heparinate. A two years' clinical study].
    Hölscher M; Zühlke V
    Med Welt; 1973 Nov; 24(46):1817-9. PubMed ID: 4592517
    [No Abstract]   [Full Text] [Related]  

  • 27. [The value of acetylsalicylic acid for the prevention of postoperative thromboembolic complications].
    Pfenninger M; Gruber UF
    Schweiz Med Wochenschr; 1977 Sep; 107(38):1335-8. PubMed ID: 918588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery.
    Nurmohamed MT; Verhaeghe R; Haas S; Iriarte JA; Vogel G; van Rij AM; Prentice CR; ten Cate JW
    Am J Surg; 1995 Jun; 169(6):567-71. PubMed ID: 7771617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of venous thromboembolism with low doses of heparin in urologic patients.
    Grgicević D; Kovacić M; Pistotnik M; Radej M
    Urology; 1977 Mar; 9(3):260-2. PubMed ID: 841798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heparin in the prevention of thromboembolism after elective hip-joint operations (author's transl)].
    Schöndorf TH
    Dtsch Med Wochenschr; 1978 Nov; 103(47):1877-81. PubMed ID: 710312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addendum to salzman paper: Efficacy of low dose heparin prophylaxis.
    Kakkar VV; Corrigan TP
    Prog Cardiovasc Dis; 1975; 17(5):367-9. PubMed ID: 1129500
    [No Abstract]   [Full Text] [Related]  

  • 32. Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis.
    Bergqvist D; Mätzsch T; Burmark US; Frisell J; Guilbaud O; Hallböök T; Horn A; Lindhagen A; Ljungnér H; Ljungström KG
    Br J Surg; 1988 Sep; 75(9):888-91. PubMed ID: 2846113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.
    Albada J; Nieuwenhuis HK; Sixma JJ
    Circulation; 1989 Oct; 80(4):935-40. PubMed ID: 2551537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The risk of hemorrhaging in the prevention of thromboembolism in general surgery: comparison of low-dose heparin and heparin-dihydergot 2500].
    Ammann JF; Aebi B
    Chirurg; 1983 Jan; 54(1):29-32. PubMed ID: 6851723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients.
    Dechavanne M; Ville D; Viala JJ; Kher A; Faivre J; Pousset MB; Dejour H
    Haemostasis; 1975; 4(2):94-100. PubMed ID: 1205340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
    Eriksson BI; Ekman S; Lindbratt S; Baur M; Bach D; Torholm C; Kälebo P; Close P
    J Bone Joint Surg Am; 1997 Mar; 79(3):326-33. PubMed ID: 9070519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prophylaxis of thrombo-embolic complications in major surgery of the hip joint. A comparative controlled study with subcutaneous calcium heparinate and acetylsalicylic acid (author's transl)].
    Hey D; Heinrich D; Burkhardt H
    Munch Med Wochenschr; 1973 Nov; 115(44):1967-70. PubMed ID: 4801763
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of aspirin on postoperative platelet kinetics and venous thrombosis.
    Clagett GP; Brier DF; Rosoff CB; Schneider PB; Salzman EW
    Surg Forum; 1974; 25(0):473-6. PubMed ID: 4439234
    [No Abstract]   [Full Text] [Related]  

  • 39. Acetylsalicylic acid pretreatment, concomitant heparin therapy and the risk of early intracranial hemorrhage following systemic thrombolysis for acute ischemic stroke.
    Schmülling S; Rudolf J; Strotmann-Tack T; Grond M; Schneweis S; Sobesky J; Thiel A; Heiss WD
    Cerebrovasc Dis; 2003; 16(3):183-90. PubMed ID: 12865603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement.
    Imperiale TF; Speroff T
    JAMA; 1994 Jun; 271(22):1780-5. PubMed ID: 7515115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.